Fairvalue-Calculator Fairvalue-Calculator
EN DE

Binect AG (MA10) Fair Value & Analysis

Technology · DE · Market cap €4.5M

Price€1.65
Fair Value€0.8200
Upside-50.3%
Quality95/100
Evidence: High Range €0.7600 – €1.02

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Binect AG (MA10) currently trades at €1.65, while our model-based Fair Value estimate is €0.8200 — implying the stock looks roughly 50.3% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Binect AG, a management holding company, engages in digitization of document-based business communication in Germany. It develops and integrates digital modules and services for medium-sized companies, authorities, and other institutions. The company was founded in 2004 and is based in Weiterstadt, Germany.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Binect AG (MA10) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €0.8200 versus a price of €1.65 — about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MA10?
Our 21-model fair value for Binect AG is €0.8200 (as of Jun 24, 2026), built from audited fundamentals. The current price is €1.65.
What is the quality score of MA10?
Binect AG has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.